Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis.

FernÁndez-Eulate G, Ruiz-Sanz JI, Riancho J, ZufirÍa M, GereÑu G, FernÁndez-TorrÓn R, Poza-Aldea JJ, Ondaro J, Espinal JB, GonzÁlez-ChinchÓn G, Zulaica M, Ruiz-Larrea MB, LÓpez De Munain A, Gil-Bea FJ.

Amyotroph Lateral Scler Frontotemporal Degener. 2020 Feb 28:1-11. doi: 10.1080/21678421.2020.1730904. [Epub ahead of print]

PMID:
32106710
2.

Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.

Cortés-Vicente E, Álvarez-Velasco R, Segovia S, Paradas C, Casasnovas C, Guerrero-Sola A, Pardo J, Ramos-Fransi A, Sevilla T, López de Munain A, Gómez MT, Jericó I, Gutiérrez-Gutiérrez G, Pelayo-Negro AL, Martín MA, Mendoza MD, Morís G, Rojas-Garcia R, Díaz-Manera J, Querol L, Gallardo E, Vélez B, Albertí MA, Galán L, García-Sobrino T, Martínez-Piñeiro A, Lozano-Veintimilla A, Fernández-Torrón R, Cano-Abascal Á, Illa I.

Neurology. 2020 Mar 17;94(11):e1171-e1180. doi: 10.1212/WNL.0000000000008903. Epub 2020 Feb 18.

PMID:
32071167
3.

ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage.

Riancho J, Castanedo-Vázquez D, Gil-Bea F, Tapia O, Arozamena J, Durán-Vían C, Sedano MJ, Berciano MT, Lopez de Munain A, Lafarga M.

J Neurol. 2020 Jan 14. doi: 10.1007/s00415-020-09704-8. [Epub ahead of print]

PMID:
31938860
4.

A deep intronic splice variant advises reexamination of presumably dominant SPG7 Cases.

Verdura E, Schlüter A, Fernández-Eulate G, Ramos-Martín R, Zulaica M, Planas-Serra L, Ruiz M, Fourcade S, Casasnovas C, López de Munain A, Pujol A.

Ann Clin Transl Neurol. 2020 Jan;7(1):105-111. doi: 10.1002/acn3.50967. Epub 2019 Dec 18.

5.

Reply to: "Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion".

De la Casa-Fages B, Fernández-Eulate G, Gamez J, Barahona-Hernando R, Morís G, García-Barcina M, Infante J, Zulaica M, Fernández-Pelayo U, Muñoz-Oreja M, Urtasun M, Olaskoaga A, Zelaya V, Jericó I, Saez-Villaverde R, Catalina I, Sola E, Martínez-Sáez E, Pujol A, Ruiz M, Schlüter A, Spinazzola A, Muñoz-Blanco JL, Grandas F, Holt I, Álvarez V, López de Munaín A.

Mov Disord. 2019 Dec;34(12):1932-1933. doi: 10.1002/mds.27899. No abstract available.

PMID:
31845766
6.

Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study.

Wang Y, Best A, Fernández-Torrón R, Alsaggaf R, Garcia-Puga M, Dagnall CL, Hicks B, Thompson M, Matheu Fernandez A, Zulaica Ijurco M, Greene MH, Lopez de Munain A, Gadalla SM.

Ann Clin Transl Neurol. 2020 Jan;7(1):126-131. doi: 10.1002/acn3.50954. Epub 2019 Dec 5.

7.

Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.

Labayru G, Diez I, Sepulcre J, Fernández E, Zulaica M, Cortés JM, López de Munain A, Sistiaga A.

Neuroimage Clin. 2019;24:102078. doi: 10.1016/j.nicl.2019.102078. Epub 2019 Nov 6.

8.

T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians.

Alberro A, Osorio-Querejeta I, Sepúlveda L, Fernández-Eulate G, Mateo-Abad M, Muñoz-Culla M, Carregal-Romero S, Matheu A, Vergara I, López de Munain A, Sáenz-Cuesta M, Otaegui D.

Aging (Albany NY). 2019 Nov 27;11(22):10723-10741. doi: 10.18632/aging.102517. Epub 2019 Nov 27.

9.

Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.

Bargiela A, Sabater-Arcis M, Espinosa-Espinosa J, Zulaica M, Lopez de Munain A, Artero R.

Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25203-25213. doi: 10.1073/pnas.1820297116. Epub 2019 Nov 21.

PMID:
31754023
10.

The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.

Bandres-Ciga S, Ahmed S, Sabir MS, Blauwendraat C, Adarmes-Gómez AD, Bernal-Bernal I, Bonilla-Toribio M, Buiza-Rueda D, Carrillo F, Carrión-Claro M, Gómez-Garre P, Jesús S, Labrador-Espinosa MA, Macias D, Méndez-Del-Barrio C, Periñán-Tocino T, Tejera-Parrado C, Vargas-González L, Diez-Fairen M, Alvarez I, Tartari JP, Buongiorno M, Aguilar M, Gorostidi A, Bergareche JA, Mondragon E, Vinagre-Aragon A, Croitoru I, Ruiz-Martínez J, Dols-Icardo O, Kulisevsky J, Marín-Lahoz J, Pagonabarraga J, Pascual-Sedano B, Ezquerra M, Cámara A, Compta Y, Fernández M, Fernández-Santiago R, Muñoz E, Tolosa E, Valldeoriola F, Gonzalez-Aramburu I, Sanchez Rodriguez A, Sierra M, Menéndez-González M, Blazquez M, Garcia C, Suarez-San Martin E, García-Ruiz P, Martínez-Castrillo JC, Vela-Desojo L, Ruz C, Barrero FJ, Escamilla-Sevilla F, Mínguez-Castellanos A, Cerdan D, Tabernero C, Gomez Heredia MJ, Perez Errazquin F, Romero-Acebal M, Feliz C, Lopez-Sendon JL, Mata M, Martínez Torres I, Kim JJ, Dalgard CL; American Genome Center, Brooks J, Saez-Atienzar S, Gibbs JR, Jorda R, Botia JA, Bonet-Ponce L, Morrison KE, Clarke C, Tan M, Morris H, Edsall C, Hernandez D, Simon-Sanchez J, Nalls MA, Scholz SW, Jimenez-Escrig A, Duarte J, Vives F, Duran R, Hoenicka J, Alvarez V, Infante J, Marti MJ, Clarimón J, López de Munain A, Pastor P, Mir P, Singleton A; International Parkinson Disease Genomics Consortium.

Mov Disord. 2019 Dec;34(12):1851-1863. doi: 10.1002/mds.27864. Epub 2019 Oct 29.

PMID:
31660654
11.

Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations.

Lasa-Elgarresta J, Mosqueira-Martín L, Naldaiz-Gastesi N, Sáenz A, López de Munain A, Vallejo-Illarramendi A.

Int J Mol Sci. 2019 Sep 13;20(18). pii: E4548. doi: 10.3390/ijms20184548. Review.

12.

Gene Correction of LGMD2A Patient-Specific iPSCs for the Development of Targeted Autologous Cell Therapy.

Selvaraj S, Dhoke NR, Kiley J, Mateos-Aierdi AJ, Tungtur S, Mondragon-Gonzalez R, Killeen G, Oliveira VKP, López de Munain A, Perlingeiro RCR.

Mol Ther. 2019 Dec 4;27(12):2147-2157. doi: 10.1016/j.ymthe.2019.08.011. Epub 2019 Aug 28.

PMID:
31501033
13.

Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism.

De la Casa-Fages B, Fernández-Eulate G, Gamez J, Barahona-Hernando R, Morís G, García-Barcina M, Infante J, Zulaica M, Fernández-Pelayo U, Muñoz-Oreja M, Urtasun M, Olaskoaga A, Zelaya V, Jericó I, Saez-Villaverde R, Catalina I, Sola E, Martínez-Sáez E, Pujol A, Ruiz M, Schlüter A, Spinazzola A, Muñoz-Blanco JL, Grandas F, Holt I, Álvarez V, López de Munaín A.

Mov Disord. 2019 Oct;34(10):1547-1561. doi: 10.1002/mds.27812. Epub 2019 Aug 21.

PMID:
31433872
14.

RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits.

Lara Ordónez AJ, Fernández B, Fdez E, Romo-Lozano M, Madero-Pérez J, Lobbestael E, Baekelandt V, Aiastui A, López de Munaín A, Melrose HL, Civiero L, Hilfiker S.

Hum Mol Genet. 2019 Nov 1;28(21):3552-3568. doi: 10.1093/hmg/ddz201.

15.

Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.

Labayru G, Aliri J, Zulaica M, López de Munain A, Sistiaga A.

J Neuropsychol. 2020 Mar;14(1):121-134. doi: 10.1111/jnp.12192. Epub 2019 Aug 13.

16.

Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT.

Fernández-Simón E, Carrasco-Rozas A, Gallardo E, González-Quereda L, Alonso-Pérez J, Belmonte I, Pedrosa-Hernández I, Montiel E, Segovia S, Suárez-Calvet X, Llauger J, Mayos M, Illa I, Barba-Romero MA, Barcena J, Paradas C, Carzorla MR, Creus C, Coll-Cantí J, Díaz M, Domínguez C, Fernández-Torrón R, García-Antelo MJ, Grau JM, López de Munáin A, Martínez-García FA, Morgado Y, Moreno A, Morís G, Muñoz-Blanco MA, Nascimento A, Parajuá-Pozo JL, Querol L, Rojas R, Robledo-Strauss A, Rojas-Marcos Í, Salazar JA, Usón M, Díaz-Manera J.

Mol Genet Metab. 2019 Sep - Oct;128(1-2):129-136. doi: 10.1016/j.ymgme.2019.07.013. Epub 2019 Jul 23.

PMID:
31378569
17.

Nonsense mutations in alpha-II spectrin in three families with juvenile onset hereditary motor neuropathy.

Beijer D, Deconinck T, De Bleecker JL, Dotti MT, Malandrini A, Urtizberea JA, Zulaica M, López de Munain A, Asselbergh B, De Jonghe P, Baets J.

Brain. 2019 Sep 1;142(9):2605-2616. doi: 10.1093/brain/awz216.

PMID:
31332438
18.

Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia.

Clos-Garcia M, Andrés-Marin N, Fernández-Eulate G, Abecia L, Lavín JL, van Liempd S, Cabrera D, Royo F, Valero A, Errazquin N, Vega MCG, Govillard L, Tackett MR, Tejada G, Gónzalez E, Anguita J, Bujanda L, Orcasitas AMC, Aransay AM, Maíz O, López de Munain A, Falcón-Pérez JM.

EBioMedicine. 2019 Aug;46:499-511. doi: 10.1016/j.ebiom.2019.07.031. Epub 2019 Jul 18.

19.

Spanish Pompe registry: Baseline characteristics of first 49 patients with adult onset of Pompe disease.

Alonso-Pérez J, Segovia S, Domínguez-González C, Olivé M, Mendoza Grimón MD, Fernández-Torrón R, López de Munain A, Muñoz-Blanco JL, Ramos-Fransi A, Almendrote M, Illa I, Díaz-Manera J.

Med Clin (Barc). 2020 Feb 14;154(3):80-85. doi: 10.1016/j.medcli.2019.03.036. Epub 2019 Jun 26. English, Spanish.

PMID:
31253477
20.

FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

Rattay TW, Lindig T, Baets J, Smets K, Deconinck T, Söhn AS, Hörtnagel K, Eckstein KN, Wiethoff S, Reichbauer J, Döbler-Neumann M, Krägeloh-Mann I, Auer-Grumbach M, Plecko B, Münchau A, Wilken B, Janauschek M, Giese AK, De Bleecker JL, Ortibus E, Debyser M, Lopez de Munain A, Pujol A, Bassi MT, D'Angelo MG, De Jonghe P, Züchner S, Bauer P, Schöls L, Schüle R.

Brain. 2019 Jun 1;142(6):1561-1572. doi: 10.1093/brain/awz102.

PMID:
31135052
21.

Author Correction: A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies.

Ezquerra-Inchausti M, Anasagasti A, Barandika O, Garay-Aramburu G, Galdós M, López de Munain A, Irigoyen C, Ruiz-Ederra J.

Sci Rep. 2019 May 28;9(1):8113. doi: 10.1038/s41598-019-44425-7.

22.

Isolation and characterization of myogenic precursor cells from human cremaster muscle.

Naldaiz-Gastesi N, Goicoechea M, Aragón IM, Pérez-López V, Fuertes-Alvarez S, Herrera-Imbroda B, López de Munain A, de Luna-Diaz R, Baptista PM, Fernández MA, Lara MF, Izeta A.

Sci Rep. 2019 Mar 5;9(1):3454. doi: 10.1038/s41598-019-40042-6.

23.

[Extensive encephalomyelitis due to Borrelia: an atypical form of neuroborreliosis].

Campo-Caballero D, Munoz-Lopetegi A, Fernandez-Garcia de Eulate G, Rodriguez-Antiguedad J, Gabilondo A, Gonzalez F, Villanua J, Lopez de Munain A.

Rev Neurol. 2019 Feb 16;68(4):169-170. Spanish.

24.

Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old.

Fernández-Eulate G, Alberro A, Muñoz-Culla M, Zulaica M, Zufiría M, Barandiarán M, Etxeberria I, Yanguas JJ, Gallardo MM, Soberón N, Lacosta AM, Pérez-Grijalba V, Canudas J, Fandos N, Pesini P, Sarasa M, Indakoetxea B, Moreno F, Vergara I, Otaegui D, Blasco M, López de Munain A.

Front Aging Neurosci. 2018 Nov 28;10:380. doi: 10.3389/fnagi.2018.00380. eCollection 2018.

25.

Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.

Idigoras Rubio I, Arana-Arri E, Portillo Villares I, Bilbao Iturribarrria I, Martínez-Indart L, Imaz-Ayo N, de la Cruz M, de Castro V, López de Munain A, Torrejón Perez I, Gutiérrez-Ibarluzea I.

Eur J Gastroenterol Hepatol. 2019 Feb;31(2):197-204. doi: 10.1097/MEG.0000000000001338.

PMID:
30543575
26.

Amyotrophic lateral sclerosis: a complex syndrome that needs an integrated research approach.

Riancho J, Gil-Bea FJ, Santurtun A, López de Munaín A.

Neural Regen Res. 2019 Feb;14(2):193-196. doi: 10.4103/1673-5374.244783. Review.

27.

Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.

Alonso-Jimenez A, Kroon RHMJM, Alejaldre-Monforte A, Nuñez-Peralta C, Horlings CGC, van Engelen BGM, Olivé M, González L, Verges-Gil E, Paradas C, Márquez C, Garibaldi M, Gallano P, Rodriguez MJ, Gonzalez-Quereda L, Dominguez Gonzalez C, Vissing J, Fornander F, Eisum AV, García-Sobrino T, Pardo J, García-Figueiras R, Muelas N, Vilchez JJ, Kapetanovic S, Tasca G, Monforte M, Ricci E, Gomez MT, Bevilacqua JA, Diaz-Jara J, Zamorano II, Carlier RY, Laforet P, Pelayo-Negro A, Ramos-Fransi A, Martínez A, Marini-Bettolo C, Straub V, Gutiérrez G, Stojkovic T, Martín MA, Morís G, Fernández-Torrón R, Lopez De Munaín A, Cortes-Vicente E, Querol L, Rojas-García R, Illa I, Diaz-Manera J.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):576-585. doi: 10.1136/jnnp-2018-319578. Epub 2018 Dec 8.

PMID:
30530568
28.

Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation Carriers.

Barandiaran M, Moreno F, de Arriba M, Indakoetxea B, Boda I, Gabilondo A, Tainta M, López de Munain A.

J Int Neuropsychol Soc. 2019 Jan;25(1):39-47. doi: 10.1017/S1355617718000735. Epub 2018 Oct 29.

PMID:
30369339
29.

A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies.

Ezquerra-Inchausti M, Anasagasti A, Barandika O, Garay-Aramburu G, Galdós M, López de Munain A, Irigoyen C, Ruiz-Ederra J.

Sci Rep. 2018 Oct 18;8(1):15457. doi: 10.1038/s41598-018-33810-3. Erratum in: Sci Rep. 2019 May 28;9(1):8113.

30.

Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?

Labayru G, Arenzana I, Aliri J, Zulaica M, López de Munain A, Sistiaga A A.

PLoS One. 2018 Sep 24;13(9):e0204227. doi: 10.1371/journal.pone.0204227. eCollection 2018.

31.

Retinoids and Amyotrophic Lateral Sclerosis.

Riancho J, Gil-Bea FJ, López de Munaín A.

JAMA Neurol. 2018 Sep 1;75(9):1153. doi: 10.1001/jamaneurol.2018.2242. No abstract available.

PMID:
30105376
32.

Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson's Disease Patients.

Yakhine-Diop SMS, Niso-Santano M, Rodríguez-Arribas M, Gómez-Sánchez R, Martínez-Chacón G, Uribe-Carretero E, Navarro-García JA, Ruiz-Hurtado G, Aiastui A, Cooper JM, López de Munaín A, Bravo-San Pedro JM, González-Polo RA, Fuentes JM.

Mol Neurobiol. 2019 Apr;56(4):2466-2481. doi: 10.1007/s12035-018-1206-6. Epub 2018 Jul 21.

PMID:
30032424
33.

Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.

Emparanza JI, López de Munain A, Greene MH, Matheu A, Fernández-Torrón R, Gadalla SM.

Muscle Nerve. 2018 Oct;58(4):517-522. doi: 10.1002/mus.26194.

34.

The panniculus carnosus muscle: an evolutionary enigma at the intersection of distinct research fields.

Naldaiz-Gastesi N, Bahri OA, López de Munain A, McCullagh KJA, Izeta A.

J Anat. 2018 Jun 12. doi: 10.1111/joa.12840. [Epub ahead of print] Review.

PMID:
29893024
35.

Expression Profiling Analysis Reveals Key MicroRNA-mRNA Interactions in Early Retinal Degeneration in Retinitis Pigmentosa.

Anasagasti A, Ezquerra-Inchausti M, Barandika O, Muñoz-Culla M, Caffarel MM, Otaegui D, López de Munain A, Ruiz-Ederra J.

Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2381-2392. doi: 10.1167/iovs.18-24091.

36.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

37.

Acetylome in Human Fibroblasts From Parkinson's Disease Patients.

Yakhine-Diop SMS, Rodríguez-Arribas M, Martínez-Chacón G, Uribe-Carretero E, Gómez-Sánchez R, Aiastui A, López de Munain A, Bravo-San Pedro JM, Niso-Santano M, González-Polo RA, Fuentes JM.

Front Cell Neurosci. 2018 Apr 17;12:97. doi: 10.3389/fncel.2018.00097. eCollection 2018.

38.

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.

Madero-Pérez J, Fdez E, Fernández B, Lara Ordóñez AJ, Blanca Ramírez M, Gómez-Suaga P, Waschbüsch D, Lobbestael E, Baekelandt V, Nairn AC, Ruiz-Martínez J, Aiastui A, López de Munain A, Lis P, Comptdaer T, Taymans JM, Chartier-Harlin MC, Beilina A, Gonnelli A, Cookson MR, Greggio E, Hilfiker S.

Mol Neurodegener. 2018 Jan 23;13(1):3. doi: 10.1186/s13024-018-0235-y.

39.

[Patients organizations and new drug approval in the US. Eteplirsen and Duchenne muscular dystrophy case].

Dal-Ré R, Lopez de Munain A, Ayuso C.

Rev Neurol. 2017 Oct 16;65(8):373-380. Review. Spanish.

40.

Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.

Gil-Bea FJ, Aldanondo G, Lasa-Fernández H, López de Munain A, Vallejo-Illarramendi A.

Expert Rev Mol Med. 2017 Jun 9;19:e7. doi: 10.1017/erm.2017.9. Review.

PMID:
28597807
41.

The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.

Moreno F, Indakoetxea B, Barandiaran M, Caballero MC, Gorostidi A, Calafell F, Gabilondo A, Tainta M, Zulaica M, Martí Massó JF, López de Munain A, Sánchez-Juan P, Lee SE.

PLoS One. 2017 Jun 8;12(6):e0178093. doi: 10.1371/journal.pone.0178093. eCollection 2017.

42.

iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology.

Matamoros-Angles A, Gayosso LM, Richaud-Patin Y, di Domenico A, Vergara C, Hervera A, Sousa A, Fernández-Borges N, Consiglio A, Gavín R, López de Maturana R, Ferrer I, López de Munain A, Raya Á, Castilla J, Sánchez-Pernaute R, Del Río JA.

Mol Neurobiol. 2018 Apr;55(4):3033-3048. doi: 10.1007/s12035-017-0506-6. Epub 2017 May 2.

43.

Progressive changes in non-coding RNA profile in leucocytes with age.

Muñoz-Culla M, Irizar H, Gorostidi A, Alberro A, Osorio-Querejeta I, Ruiz-Martínez J, Olascoaga J, López de Munain A, Otaegui D.

Aging (Albany NY). 2017 Apr;9(4):1202-1218. doi: 10.18632/aging.101220.

44.

Nontraditional Lipid Variables Predict Recurrent Brain Ischemia in Embolic Stroke of Undetermined Source.

de la Riva P, Zubikarai M, Sarasqueta C, Tainta M, Muñoz-Lopetegui A, Andrés-Marín N, González F, Díez N, de Arce A, Bergareche A, Lopez de Munain A, Martínez-Zabaleta M.

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1670-1677. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.024. Epub 2017 Apr 13.

PMID:
28412318
45.

FRZB and melusin, overexpressed in LGMD2A, regulate integrin β1D isoform replacement altering myoblast fusion and the integrin-signalling pathway.

Jaka O, Casas-Fraile L, Azpitarte M, Aiastui A, López de Munain A, Sáenz A.

Expert Rev Mol Med. 2017 Mar 16;19:e2. doi: 10.1017/erm.2017.3.

PMID:
28300015
46.

Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014).

Arruti M, Piñeiro LD, Salicio Y, Cilla G, Goenaga MA, López de Munain A.

J Neurovirol. 2017 Jun;23(3):451-459. doi: 10.1007/s13365-017-0519-y. Epub 2017 Feb 21.

PMID:
28224485
47.

High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa.

Ezquerra-Inchausti M, Barandika O, Anasagasti A, Irigoyen C, López de Munain A, Ruiz-Ederra J.

Sci Rep. 2017 Jan 3;7:39652. doi: 10.1038/srep39652.

48.

Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons.

López de Maturana R, Lang V, Zubiarrain A, Sousa A, Vázquez N, Gorostidi A, Águila J, López de Munain A, Rodríguez M, Sánchez-Pernaute R.

J Neuroinflammation. 2016 Nov 18;13(1):295.

49.

Dominant LGMD2A: alternative diagnosis or hidden digenism?

Sáenz A, López de Munain A.

Brain. 2017 Feb;140(2):e7. doi: 10.1093/brain/aww281. Epub 2016 Nov 5. No abstract available.

PMID:
27818383
50.

Association of lifestyle, inflammatory factors, and dietary patterns with the risk of suffering a stroke: A case-control study.

Abete I, Zulet MA, Goyenechea E, Blazquez V, de Arce Borda AM, Lopez de Munain A, Martinez JA.

Nutr Neurosci. 2018 Jan;21(1):70-78. doi: 10.1080/1028415X.2016.1226473. Epub 2016 Sep 7.

PMID:
27603597

Supplemental Content

Loading ...
Support Center